Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
about
Molecular imaging of integrin αvβ6 expression in living subjects.A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or densityIntegrin-mediated regulation of epidermal wound functionsFibronectin-guided migration of carcinoma collectivesNMR relaxation and structural elucidation of peptides in the presence and absence of trifluoroethanol illuminates the critical molecular nature of integrin αvβ6 ligand specificity.From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarkerEvaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptideWhy integrin as a primary target for imaging and therapy.Structural guided scaffold phage display libraries as a source of bio-therapeutics.Generation and characterization of a diabody targeting the αvβ6 integrin.αvβ6- and αvβ8-integrins serve as interchangeable receptors for HSV gH/gL to promote endocytosis and activation of membrane fusion.Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆Cloning and characterization of the human integrin β6 gene promoterFusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL.α(V)β(6) integrin expression is induced in the POET and Pten(pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma.Cell signals influencing hepatic fibrosisImmunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas.Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers.Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function.In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8.Endocytosis and spatial restriction of cell signaling.Defining the role of integrin alphavbeta6 in cancer.Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancerClinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection.Epithelial integrins with special reference to oral epithelia.Integrin modulators: a patent review.Chromogranin A: a paradoxical player in angiogenesis and vascular biology.Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.ImmunoPET Imaging of αvβ6 Expression Using an Engineered Anti-αvβ6 Cys-diabody Site-Specifically Radiolabeled with Cu-64: Considerations for Optimal Imaging with Antibody Fragments.THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).Switch from αvβ5 to αvβ6 integrin is required for CD9-regulated keratinocyte migration and MMP-9 activation.Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
P2860
Q27007536-EBA7E5CC-5372-4E24-B136-A668ECF86D50Q27308658-5B2D0593-26F2-4494-AC72-E8257DD39A85Q28388577-96B3ADDE-1AF7-42DD-B3AF-0FD2EFAA0009Q30835803-3BC4E72C-2313-4A28-84A1-4FE0EC92F668Q31096250-6F17A610-489B-4995-8E28-BFF91AF19FD1Q34491680-39F82E7D-BCBF-4313-B27C-F6D79C91B9C5Q34870617-6D1B71F9-AD6D-4EEC-B706-60FA7BBA1C8BQ34912582-5DBA146D-4E64-41CF-BB5F-5B89915E8E4BQ34946977-727DB473-1397-4566-9464-07D901F30E5FQ34984328-1182EAE5-3257-4F78-AB28-84DBC4156115Q35075118-61EA1ADD-A395-472A-A4AB-6F2D0B5EAE2AQ35368323-BFFCE48D-74FE-4D4F-B6D1-9434AC1B5AF3Q35588772-D00D803C-8ECD-476B-B7D2-091E5298E509Q35599292-B4155479-C3A2-4290-9189-3DBA62E7F342Q35964178-DA2B0C9D-3D2A-4028-9343-7DF5F4F83F7AQ36220879-A79B03A8-DB8E-49C3-9866-1A874796DC47Q36230578-E9AA523B-CCCA-4586-AB7C-0CF777E4B9AFQ36857755-7A633D4A-77AF-4827-AC4B-5971FDA0F2DCQ37039386-0D185244-8285-4A79-ADF8-4AB2C27CD461Q37228570-D9117683-A6BB-418C-9EE4-7402D0FF9856Q37232834-9CAF680B-B550-404A-8216-DE9E84536891Q37317439-CD402BF1-3E14-4BD8-AEAC-D49BD0927521Q37453542-40A96A76-5867-4E14-B891-71591A289CDFQ37537921-CFB0BD64-40D1-4A4A-9616-EDFC5A7B7CFBQ37550644-256D444C-0BD9-40FF-B994-240F0DA6FC32Q37603527-A321BEA6-C3FB-4158-8F4E-FC86CA288C72Q37604903-113536D0-17FC-4372-906C-FD46D8B0195EQ37746036-F1EA2926-4BB7-4CB5-98EB-555FB1D05385Q37750805-9A692CDE-89F6-42F9-B28B-2829DC42225BQ37823103-40B2580E-7AB6-465F-8C9C-9D813939CCA2Q37858271-812BBF8C-5E6F-480A-8838-959F0B075025Q38139612-00D47048-58BA-4956-BD56-F5F96896115DQ38258283-C92F50DC-E31D-4E94-AA48-8FD64040D366Q38385221-1301BFEF-64F8-4A34-85B4-CF5B9AAB2CC8Q38399145-CF2B17CA-9A8F-4AFC-8D38-D6160D444AC9Q38666311-FA7ED13A-9040-47B9-BB27-B232CE5CABB6Q38737180-F4C51B33-CEC8-4028-80EB-27973FDC3E2AQ38821208-F33B393E-DE5B-4164-AF02-20245F95F6D9Q38952358-10987BC0-4362-424B-A3CF-B3F0852309B0Q39020546-4003EF94-596C-43F8-AB77-A973D4F8CFAB
P2860
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
@ast
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
@en
type
label
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
@ast
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
@en
prefLabel
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
@ast
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
@en
P2093
P2860
P1476
Alphavbeta6 integrin in wound healing and cancer of the oral cavity.
@en
P2093
Marshall JF
Nyström ML
P2860
P356
10.1111/J.1600-0714.2005.00374.X
P577
2006-01-01T00:00:00Z